October 16, 2017 / 5:06 AM / 2 months ago

BRIEF-Probiodrug initiates phase 2B core program of PQ912

Oct 16 (Reuters) - PROBIODRUG AG:

* PROBIODRUG INITIATES PHASE 2B CORE PROGRAM OF PQ912 AND DETAILS FURTHER STRATEGY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below